Alert: rowley law pllc is investigating proposed acquisition of revance therapeutics, inc.

New york , aug. 12, 2024 /prnewswire/ -- rowley law pllc is investigating potential securities law violations by revance therapeutics, inc. (nasdaq: rvnc) and its board of directors concerning the proposed acquisition of the company by crown laboratories, inc. stockholders will receive $6.66 for each share of revance therapeutics stock that they hold. the transaction is valued at approximately $924 million and is expected to close by the end of 2024.
RVNC Ratings Summary
RVNC Quant Ranking